Financial Snapshot

Revenue
$935.8K
TTM
Gross Margin
83.13%
TTM
Net Earnings
$103.8K
TTM
Current Assets
Q4 2023
Current Liabilities
Q4 2023
Current Ratio
11.3%
Q4 2023
Total Assets
Q4 2023
Total Liabilities
Q4 2023
Book Value
-$78.73K
Q4 2023
Cash
Q4 2023
P/E
5.408K
Nov 27, 2024 EST
Free Cash Flow
-$204.5K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020
Revenue $882.5K $448.8K $879.3K $134.7K
YoY Change 96.65% -48.96% 552.7%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020
Revenue $882.5K $448.8K $879.3K $134.7K
Cost Of Revenue $116.1K $515.5K $1.056M $40.65K
Gross Profit $766.4K -$66.67K -$176.2K $94.07K
Gross Profit Margin 86.84% -14.86% -20.04% 69.83%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020
Selling, General & Admin $541.0K $576.0K $301.0K $85.23K
YoY Change -6.08% 91.39% 253.12%
% of Gross Profit 70.59% 90.6%
Research & Development $118.4K $25.05K $0.00
YoY Change 372.79%
% of Gross Profit 0.0%
Depreciation & Amortization $56.76K $24.76K $420.00 $110.00
YoY Change 129.23% 5795.24% 281.82%
% of Gross Profit 7.41% 0.12%
Operating Expenses $541.0K $576.0K $301.0K $85.34K
YoY Change -6.08% 91.39% 252.67%
Operating Profit $225.4K -$642.7K -$477.2K $8.730K
YoY Change -135.07% 34.69% -5565.98%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020
Interest Expense $26.54K $71.77K $12.35K -$20.27K
YoY Change -63.03% 481.15% -160.93%
% of Operating Profit 11.77% -232.19%
Other Income/Expense, Net -$26.07K -$76.60K -$13.48K $10.00
YoY Change -65.97% 468.45% -134850.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020
Pretax Income $199.3K -$415.1K -$119.4K -$11.53K
YoY Change -148.01% 247.72% 935.39%
Income Tax -$42.22K $792.00 $351.00 $1.940K
% Of Pretax Income -21.18%
Net Earnings $823.9K -$720.1K -$491.0K -$13.48K
YoY Change -214.41% 46.66% 3542.48%
Net Earnings / Revenue 93.35% -160.45% -55.84% -10.01%
Basic Earnings Per Share $0.01 -$0.01 $0.00
Diluted Earnings Per Share $0.01 -$0.01 $0.00 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020
Cash & Short-Term Investments $15.28K $6.630K $99.68K
YoY Change 130.47% -93.35%
Cash & Equivalents $15.28K $6.630K $99.68K
Short-Term Investments
Other Short-Term Assets $195.4K $485.4K $27.41K
YoY Change -59.75% 1670.96%
Inventory $480.4K
Prepaid Expenses
Receivables $358.0K
Other Receivables $152.9K
Total Short-Term Assets $331.0K $501.6K $1.118M
YoY Change -34.01% -55.15%
Property, Plant & Equipment $3.048M $253.7K $1.986M
YoY Change 1101.7% -87.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $42.82K $1.350M $146.0K
YoY Change -96.83% 824.15%
Total Long-Term Assets $3.091M $1.603M $2.132M
YoY Change 92.81% -24.81%
Total Assets $3.422M $2.105M $3.251M
YoY Change
Accounts Payable $2.808M $0.00 $111.7K
YoY Change -100.0%
Accrued Expenses $106.3K $57.11K $122.2K
YoY Change 86.15% -53.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.929M $2.521M $2.909M
YoY Change 16.17% -13.33%
Long-Term Debt $431.1K $414.0K $414.0K
YoY Change 4.13% 0.0%
Other Long-Term Liabilities $141.0K $121.1K $203.3K
YoY Change 16.46% -40.46%
Total Long-Term Liabilities $572.1K $535.1K $617.3K
YoY Change 6.92% -13.33%
Total Liabilities $3.501M $3.056M $3.526M
YoY Change 14.55% -13.33%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020
Basic Shares Outstanding 111.1M shares 104.4M shares 100.0M shares
Diluted Shares Outstanding 111.1M shares 104.4M shares 100.0M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $561.16 Million

About Cordyceps Sunshine Biotech Holdings Co., Ltd.

Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in the cultivating and sale of cordyceps. The company is headquartered in Taipei City, Taipei and currently employs 15 full-time employees. The company went IPO on 2023-10-09. The primary product is Cordyceps, Ophiocordyceps Sinensis, a valuable Chinese medicinal material with a long history of application in China. The firm produces two kinds of Cordyceps, including dry Cordyceps and fresh Cordyceps. Dry cordyceps has a long shelf life and is convenient to store and carry, fresh Cordyceps has a short shelf life and is inconvenient to store and carry. The products are cultivated in its breeding center. The firm commissioned third party quality testing institution to perform quality testing for products to ensure quality control.

Industry: Medicinal Chemicals & Botanical Products Peers: